BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16707059)

  • 1. Guillain-Barré syndrome, greater Paris area.
    Sivadon-Tardy V; Orlikowski D; Rozenberg F; Caudie C; Sharshar T; Lebon P; Annane D; Raphaël JC; Porcher R; Gaillard JL
    Emerg Infect Dis; 2006 Jun; 12(6):990-3. PubMed ID: 16707059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris].
    Sivadon V; Orlikowski D; Rozenberg F; Quincampoix JC; Caudie C; Durand MC; Fauchère JL; Sharshar T; Raphaël JC; Gaillard JL
    Pathol Biol (Paris); 2005; 53(8-9):536-8. PubMed ID: 16084033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of Campylobacter jejuni-associated Guillain-Barré syndromes in the Greater Paris area.
    Sivadon-Tardy V; Porcher R; Orlikowski D; Ronco E; Gault E; Roussi J; Durand MC; Sharshar T; Annane D; Raphael JC; Megraud F; Gaillard JL
    Epidemiol Infect; 2014 Aug; 142(8):1609-13. PubMed ID: 24107359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Campylobacter jejuni infection elicit axonal or demyelinating Guillain-Barré syndrome, or both?
    Kuwabara S
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):238. PubMed ID: 21325023
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
    Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
    Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
    Tsang RS
    Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome post renal transplant: A systematic review.
    Ostman C; Chacko B
    Transpl Infect Dis; 2019 Feb; 21(1):e13021. PubMed ID: 30403433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
    Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
    Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A descriptive study of Guillain-Barré syndrome in high and low Campylobacter jejuni incidence regions of Michigan: 1992-1999.
    Church Potter R; Kaneene JB
    Neuroepidemiology; 2003; 22(4):245-8. PubMed ID: 12792145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guillain-Barre syndrome and Campylobacter].
    Engberg JH
    Ugeskr Laeger; 2002 Dec; 164(50):5905-8. PubMed ID: 12553106
    [No Abstract]   [Full Text] [Related]  

  • 13. Campylobacter jejuni O:19 serotype-associated Guillain-Barré syndrome in a child: the first case reported from Greece.
    Chatzipanagiotou S; Kilidireas K; Trimis G; Nicolaou C; Anagnostouli M; Athanassaki C; Giannoulia A; Legakis N; Youroukos S
    Clin Microbiol Infect; 2003 Jan; 9(1):69-72. PubMed ID: 12691547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study on children with Guillain-Barre syndrome in North China.
    Liu GF; Wu ZL; Wu HS; Wang QY; Zhao-Ri GT; Wang CY; Liang ZX; Cui SL; Zheng JD
    Biomed Environ Sci; 2003 Jun; 16(2):105-11. PubMed ID: 12964782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?
    Berciano J; Illa I
    Neurology; 2005 Feb; 64(4):766-7; author reply 766-7. PubMed ID: 15728323
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study.
    Kalra V; Chaudhry R; Dua T; Dhawan B; Sahu JK; Mridula B
    J Child Neurol; 2009 Jun; 24(6):664-8. PubMed ID: 19491112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of factors associated with the development of Guillain-Barré syndrome 2007-2017: what has changed?
    Wachira VK; Peixoto HM; de Oliveira MRF
    Trop Med Int Health; 2019 Feb; 24(2):132-142. PubMed ID: 30444562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study.
    Tam CC; Rodrigues LC; Petersen I; Islam A; Hayward A; O'Brien SJ
    J Infect Dis; 2006 Jul; 194(1):95-7. PubMed ID: 16741887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001.
    Tam CC; Rodrigues LC; O'Brien SJ
    Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.